The MarketWatch News Department was not involved in the creation of this content. The Novo Nordisk Foundation proposes new candidates for election as members of the Board of Directors of Novo Nordisk ...

(Bloomberg) -- When the chairman of the foundation that controls Danish weight-loss drug giant Novo Nordisk A/S dismissed its chief executive and then much of the board, it upended the country’s ...

On Friday, Novo Nordisk held its Extraordinary General Meeting, which was convened to elect new members of the Board of Directors. At the Extraordinary General Meeting, Helge Lund (chair), Henrik ...

COPENHAGEN (Reuters) -Newly-elected chairman of Wegovy-maker Novo Nordisk, Lars Rebien Sorensen, said on Friday he plans to enhance the board’s pharmaceutical and over-the-counter experience following ...

Novo Nordisk NVO has moved to convene an Extraordinary General Meeting (EGM) after a rare and public disagreement over board composition between its current board of directors and the Novo Nordisk ...

Novo Nordisk, the Danish pharmaceutical giant behind the blockbuster weight loss drugs Wegovy and Ozempic, is facing a major corporate upheaval with the resignation of Chairman Helge Lund and six ...

Novo Nordisk said it would replace its chairman and other board members after the Danish pharma giant's controlling shareholder pushed for more changes to revive the company's success in the ...

Armed with hundreds of thousands of dollars from Newman’s Own Foundation and Ozempic creator Novo Nordisk, young Native Americans are leading the fight against persistently high rates of food ...

On Friday, Novo Nordisk A/S' (NYSE: NVO) board director Mikael Dolsten said he will not seek election to the Board of Directors at the upcoming extraordinary general meeting on 14 November 2025.